Venticute

a recombinant surfactant protein C-based surfactant preparation

Networked: 3 relevant articles (0 outcomes, 2 trials/studies)

1.	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/01/2003 - "We performed a phase I/II trial in North America of a recombinant surfactant protein C-based surfactant (Venticute) as treatment for the acute respiratory distress syndrome. "
2.	Inflammation (Inflammations) 06/01/2009 - "In the present study, the effects of an animal-derived surfactant (Curosurf) and a synthetic surfactant (Venticute) on lipopolysaccharide (LPS)-induced inflammation were tested in human monocyte THP-1 cells. "
3.	Lung Injury 06/01/2002 - "We asked if the initial lung injury response differed when preterm ventilated lambs were treated with complete natural sheep surfactant, a lipid extract of sheep surfactant, a surfactant used to treat RDS (Survanta), or a synthetic surfactant containing recombinant SP-C (Venticute). "

1.	Surface-Active Agents (Surfactants)
2.	Protein C
3.	Lipopolysaccharides
4.	poractant alfa (Curosurf)
5.	Lipids
6.	beractant (Survanta)